1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Needle-Free Injection Systems Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Needle-Free Injection Systems Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. North America Needle-Free Injection Systems Market Regional Analysis
6.1 North America Needle-Free Injection Systems Market Overview
6.2 North America Needle-Free Injection Systems Market Revenue 2020-2028 (US$ Million)
6.3 North America Needle-Free Injection Systems Market Forecast Analysis
7. North America Needle-Free Injection Systems Market Analysis – by Product
7.1 Fillable Needle-free Injectors and Prefilled Needle-free Injectors
- 7.1.1 Overview
- 7.1.2 Fillable Needle-free Injectors and Prefilled Needle-free Injectors: North America Needle-Free Injection Systems Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Needle-Free Injection Systems Market Analysis – by Technology
8.1 Jet-Based Needle-free Injectors
- 8.1.1 Overview
- 8.1.2 Jet-Based Needle-free Injectors: North America Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Spring-Based Needle-free Injectors
- 8.2.1 Overview
- 8.2.2 Spring-Based Needle-free Injectors: North America Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Microarray Patch Injectors
- 8.3.1 Overview
- 8.3.2 Microarray Patch Injectors: North America Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Needle-Free Injection Systems Market Analysis – by Type
9.1 Liquid-Based Needle-free Injectors
- 9.1.1 Overview
- 9.1.2 Microarray Patch Injectors: North America Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Projectile-based Needle-free Injectors
- 9.2.1 Overview
- 9.2.2 Microarray Patch Injectors: North America Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Powder-Based Needle-free Injectors
- 9.3.1 Overview
- 9.3.2 Microarray Patch Injectors: North America Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Needle-Free Injection Systems Market – North America Analysis
10.1 North America
- 10.1.1 North America Needle-Free Injection Systems Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.1.1.1 North America Needle-Free Injection Systems Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 US: North America Needle-Free Injection Systems Market Breakdown, by Product
- 10.1.1.1.2 US: North America Needle-Free Injection Systems Market Breakdown, by Technology
- 10.1.1.1.3 US: North America Needle-Free Injection Systems Market Breakdown, by Type
- 10.1.1.2 Canada:
North America Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Canada: North America Needle-Free Injection Systems Market Breakdown, by Product
- 10.1.1.2.2 Canada: North America Needle-Free Injection Systems Market Breakdown, by Technology
- 10.1.1.2.3 Canada: North America Needle-Free Injection Systems Market Breakdown, by Type
- 10.1.1.3 Mexico :
North America Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Mexico : North America Needle-Free Injection Systems Market Breakdown, by Product
- 10.1.1.3.2 Mexico : North America Needle-Free Injection Systems Market Breakdown, by Technology
- 10.1.1.3.3 Mexico : North America Needle-Free Injection Systems Market Breakdown, by Type
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Needle-Free Injection Systems Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Aijex Pharma International Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Crossject
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Ferring B.V.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Medical International Technologies (MIT Canada) Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 National Medical Products, Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 NOVIO Pharmaceuticals
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 NuGen Medical Devices
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 PharmaJet
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Portal Instruments
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Zealand Pharma A/S
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights